Stock Price
6.23
Daily Change
-0.23 -3.56%
Monthly
-0.80%
Yearly
60.57%
Q2 Forecast
6.10

Ardelyx reported $-0.15 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q1 Mar/2026 -0.15 -0.12 -0.17 Apr/30




Eps Change Date
Abbott USD 1.15 0.35 Mar/2026
Amgen USD 5.15 0.14 Mar/2026
Ardelyx USD -0.15 0.15 Mar/2026
aTyr Pharma USD 0.53 0.8 Dec/2025
Corcept Therapeutics USD -0.3 0.5 Mar/2026
Curis USD 1.23 3.26 Dec/2025
Sanofi EUR 2.17 2.84 Mar/2026
TG Therapeutics USD 0.12 0.02 Mar/2026
United Therapeutics USD 5.82 1.88 Mar/2026
Xoma USD -1.59 2.43 Sep/2024